Paul Miller, DVM, DACVO, Clinical Professor

Department of Surgical Sciences
Office: 2062

Paul Miller, DVM, DACVO, Clinical Professor

Titles and Education

  1. Clinical Professor of Comparative Ophthalmology

  2. BS 1982, Michigan State University
  3. DVM 1983, Michigan State University
  4. Diplomate, American College of Veterinary Ophthalmologists


Dr. Miller's principal research interests are the regulation of intraocular pressure in both health and glaucoma and comparative ocular pharmacology.  His primary research emphasis has been to standardize methods of determining intraocular pressure (tonometry) and to elucidate the mechanisms by which glaucoma occurs in the dog, specifically as to why the drainage closes in canine primary angle-closure glaucoma. Additionally, he has an interest in clinically applicable methods of maintaining vision in dogs with glaucoma. He has also worked extensively in the area of comparative ocular pharmacology and toxicology.


Comparative ophthalmology in the third year of the professional curriculum and the clinical rotation in Comparative Ophthalmology for senior students; continuing education for private practitioners and resident-level training. Dr. Miller also has edited Slatter's Fundamentals of Veterinary Ophthalmology, the ophthalmology section fo the Five Minute Veterinary Consult and has authored over 75 book chapters, 100 formal scientific manuscripts and has given over 450 formal presentations at national and international meetings.

Clinical Interests

Comparative ophthalmology with a special emphais on glaucoma and ocular pharmacology and toxicology

Recent Publications

  1. Maggs DJ, Miller PE, Ofri R. Slatter’s Fundamentals of Veterinary Ophthalmology, Sixth edition. Saunders Elsevier: St Louis. Mo. 2017. Also Translated into French, Polish, Portuguese, Spanish and Korean.

  2. Dubin A, Bentley E. Miller PE.  Evaluation and Identification of Risk Factors for Primary Angle Closure Glaucoma in Bouvier Des Flandres Dogs. Journal of the American Medical Association.  January 2017 250(1):60-7
  3. Smith LN, Miller PE.  Effects of topical administration of latanoprost, timolol or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs.  American Journal of Veterinary Research 2010:71:1055-61.
  4. Nork TM, Murphy CJ, Kim CBY, Ver Hoeve JN, Rasmussen CA, Miller PE, Wabers HD, Neider MW, Dubielzig RR, McCulloh RJ, Christian BJ. Functional and Anatomic Consequences of Subretinal Dosing in the Cynomolgus Macaque. Archives of Ophthalmology, 2012; 130(1):65-75 (Epub ahead of print 2011 Sep 12).
  5. Murphy CJ, Bentley E, Miller PE, McIntyre K, Leatherberry G, Dubielzig D, Giuliano E, Moore CP, Phillips TE, Scagliotti R, Esson D, Gadek T, O’Neill C.  The Pharmacological Assessment of a Novel Lymphocyte Function-Associated Antigen-1 Antagonist (SAR 1118) for the Treatment of Keratoconjuncti
  6. Eaton JS, Miller PE, Bentley E. Thomasy SM, Murphy CJ.  Slit lamp-based ocular scoring systems in toxicology and drug development: a literature review and comparison.  Journal of Ocular Pharmacology and Therapeutics 2017;33(10):707-17

  7. Eaton JS, Miller PE, Bentley E, Thomasy SM, Murphy CJ. The SPOTS System: An Ocular Scoring System Optimized for Use in Modern Preclinical Drug Development and Toxicology.  Journal of Ocular Pharmacology and Therapeutics. 2017;33(10):718-734

  8. Miller PE, Tilley LP, Smith FWK (eds). Ophthalmology: The Five-Minute Veterinary Consult Canine and Feline Speciality Handbook. Lippincott Williams & Wilkins; Baltimore MD 2006; 306 pages. ISBN 0-7817-7063-7.  Also translated into Japanese.